---
title: 'PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer
  medicine in Europe'
date: '2024-05-23'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38779910/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240523183437&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: European collaboration can facilitate the implementation
  of PCM and thereby provide affordable and equitable access to precision diagnostics
  and matched therapies for more patients. ble from the PCM4EU website (http://www.pcm4eu.eu).
  The first reports, including an overview of requirements for the reimbursement systems
  in participating countries and a guide on patient involvement, are expected to be
  published in ...'
disable_comments: true
---
CONCLUSION: European collaboration can facilitate the implementation of PCM and thereby provide affordable and equitable access to precision diagnostics and matched therapies for more patients. ble from the PCM4EU website (http://www.pcm4eu.eu). The first reports, including an overview of requirements for the reimbursement systems in participating countries and a guide on patient involvement, are expected to be published in ...